Arimidex is now approved to treat EARLY breast cancer

October 2002

Arimidex is now approved to treat EARLY breast cancer.

Tamoxifen is currently the standard for women with estrogen receptor-positive breast cancer.

Both tamoxifen and Arimidex reduce the effect of estrogen on tumor cells...but they work in different ways. Tamoxifen blocks estrogen receptors...Arimidex suppresses estrogen synthesis.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote